Bayer Accounts Payable 2010-2025 | BAYRY

Bayer accounts payable for the quarter ending March 31, 2025 were $6.939B, a 0.1% decline year-over-year.

  • Bayer accounts payable for 2024 were $8.135B, a 0.81% increase from 2023.
  • Bayer accounts payable for 2023 were $8.07B, a 1.51% increase from 2022.
  • Bayer accounts payable for 2022 were $7.949B, a 1.07% decline from 2021.

Bayer Accounts Payable 2010-2025 | BAYRY

  • Bayer accounts payable for 2024 were $8.135B, a 0.81% increase from 2023.
  • Bayer accounts payable for 2023 were $8.07B, a 1.51% increase from 2022.
  • Bayer accounts payable for 2022 were $7.949B, a 1.07% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.8B
Johnson & Johnson (JNJ)$422.5B
AbbVie (ABBV)$367.3B
Novartis AG (NVS)$267.2B
Roche Holding AG (RHHBY)$260.1B
Novo Nordisk (NVO)$250.5B
Merck (MRK)$207.8B
Pfizer (PFE)$139.9B
Sanofi (SNY)$122.6B
Innoviva (INVA)$1.3B